TECH Novinky na Forexe
Bio-Techne Q2 Results Miss Estimates; Declares Dividend
Life sciences company Bio-Techne Corp. (TECH) reported Thursday that second-quarter net earnings attributable to the company almost halved to $27.47 million or $0.17 per share from $50.01 million or $0.31 per share in the prior-year quarter.
RTTNews
|
Pred 328 dňami
Bio-Techne Files Drug Master File With FDA For ExCellerate GMP IPSC Expansion Medium
Bio-Techne Corp. (TECH) announced Wednesday that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA) for its ExCellerate GMP iPSC Expansion Medium, Animal Free (CCM0036-GMP), supporting the development and manufacture of regenerative medicine and stem cell therapies.
RTTNews
|
Pred 371 dňami
Bio-Techne Promotes Kim Kelderman To Succeed Chuck Kummeth As President And CEO
Bio-Techne Corp. (TECH) announced Thursday that its Board of Directors appointed Kim Kelderman as President and Chief Executive Officer, effective February 1, 2024. Kelderman will also become a member of the Board of Directors on the same day.
RTTNews
|
Pred 433 dňami
Bio-Techne, Akoya To End Co-development Of RNAscope For Use With PhenoCycler-Fusion System
Life sciences company Bio-Techne Corp. (TECH) announced Monday that the company will end their collaboration with Akoya Biosciences to co-develop an automated RNAscope workflow for use with the PhenoCycler-Fusion System. The decision was made following best efforts to achieve the intended program goals.
RTTNews
|
Pred 499 dňami
Bio-Techne To Acquire Namocell For Undisclosed Terms
Life sciences company Bio-Techne Corp. (TECH) announced Wednesday it has reached an agreement to acquire Namocell, Inc., a provider of fast and easy to use single cell sorting and dispensing platforms that are gentle to cells, and preserve cell viability and integrity.
RTTNews
|
Pred 917 dňami
